Purchase Order HHSN275201800162P
Award Date 2/13/18
Potential Completion Date 5/14/19
Potential Value $45K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for a $28,172.64 firm fixed price purchase order issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for specialized metabolomics analysis services to support NIDDK research, specifically the development of a diagnostic test to monitor the progression of Type 1 Diabetes. Metabolon will leverage its proprietary UHPLC-MS/MS platform and statistical...
- This is a $40,500 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a study comparing patients with lipodystrophy to patients with insulin receptor mutations. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker...
- The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), awarded a sole-source contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic analysis services. The $28,991.20 firm-fixed-price purchase order is to support the Liver Diseases Branch's research on microbiomes and their effects on host physiology and immune responses. Metabolon will use ultra-high performance liquid chromatography...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
- This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
- This is a $17,000 federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a small disadvantaged business, for metabolite analysis services. The contract is not set aside. Metabolon is a leading provider of metabolomics solutions that leverages proprietary technology to identify and quantify metabolites from biological samples. This contract supports NIDDK's research initiatives, such as the analysis of serum...
- The NIH Clinical Center awarded a $24,784 firm fixed-price purchase order to Metabolon, Inc. for metabolomics analysis services. The contract, which commenced on September 9, 2025, with an ultimate completion date of September 8, 2026, represents a task order under Metabolon's existing Indefinite Delivery Contract with the NIH Clinical Center valued at $250,000. No set-aside designation was utilized for this award. Metabolon, a self-certified small disadvantaged business headquartered in...
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $24,948.00 firm fixed price purchase order is for a complex lipid panel analysis of 56 samples. The contract has no set-aside designation. Metabolon is a leading provider of specialized metabolomics analysis services, leveraging its proprietary platforms to support a wide range of federal...
- This is a federal contract award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business, for $21,600.00. The contract is for the acquisition of metabolic profiling of mouse livers. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. The company has served as...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for the collection and analysis of 48 24-hour urine samples from a low-calorie-low-fat (LCLF) diet intervention study. Metabolon, a leading provider of metabolomics services, will leverage its proprietary analytical platforms to identify and quantify metabolites...